Clinical trials
Active, not recruiting Phase 2 Stomach Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 7 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 3 |
| National Cancer Institute (NCI) | 3 |
| AstraZeneca | 2 |
| Henan Cancer Hospital | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| The Netherlands Cancer Institute | 2 |
| Arcus Biosciences, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Aston Sci. Inc. | 1 |
| Gruppo Oncologico del Nord-Ovest | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 37 |
| Esophageal Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Breast Neoplasms | 3 |
| Microsatellite Instability | 3 |
| Pancreatic Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Merkel Cell | 2 |
| Carcinoma, Renal Cell | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.